(a) In this subtitle the following words have the meanings indicated. (b) “Commissioner of Health” means the Baltimore City Commissioner of Health. (c) “HIV” means the human immunodeficiency virus that causes acquired immune deficiency syndrome (AIDS). (d) “Participant” means an individual who has registered with the Program. (e) “Program” means the AIDS Prevention Sterile Needle and Syringe Exchange Pilot Program. […]
(a) There is an AIDS Prevention Sterile Needle and Syringe Exchange Pilot Program in the Baltimore City Health Department. (b) The Program shall: (1) Provide for the exchange by participants of used hypodermic needles and syringes for sterile hypodermic needles and syringes; and (2) Operate in accordance with the procedures approved, with the advice and approval of the oversight […]
The Program shall: (1) Be designed and maintained to provide maximum security of exchange locations and equipment, including security measures that may be required to control the use and dispersal of hypodermic needles and syringes and security measures that allow for a full accounting of the number of hypodermic needles and syringes in circulation and the […]
(a) The Mayor of Baltimore City shall appoint an oversight committee for the Program. (b) The oversight committee shall consist of: (1) Two representatives from academia who specialize in public health issues; (2) One representative from law enforcement, nominated by the Secretary of the Department of Public Safety and Correctional Services; (3) One representative of the Baltimore City Police Department; […]
(a) The Commissioner of Health shall appoint a Director for the Program. (b) With the advice and approval of the oversight committee, the Director shall develop: (1) Program operating procedures for the furnishing and exchange of hypodermic needles and syringes to injecting drug users; (2) A community outreach and education program; and (3) A protocol for providing a linkage for […]
(a) The Baltimore City Health Department shall include in its Program operating procedures measures to collect the following data: (1) The number of participants served by the Program; (2) The length of time a participant is served by the Program; (3) Demographic profiles of participants served by the Program that include: (i) Age; (ii) Sex; (iii) Race; (iv) Occupation; (v) Zip code of residence; […]
(a) (1) Each Program participant shall be issued an identification card with an identification number. (2) The identification number shall be cross-indexed to a confidential record containing pertinent data on the participant. (b) Any information obtained by the Program that would identify Program participants, including Program records, is: (1) Confidential; (2) Not open to public inspection or disclosure; and (3) Not discoverable […]
(a) No Program staff member or Program participant may be found guilty of violating § 5-601, § 5-619, § 5-620, § 5-902, or § 5-904 of the Criminal Law Article for possessing or distributing controlled paraphernalia or drug paraphernalia whenever the possession or distribution of the controlled paraphernalia or drug paraphernalia is a direct result of […]
Except for violations of any laws that could arise from residue attached to or contained within hypodermic needles or syringes being returned or already returned to the Program, nothing in this subtitle provides immunity to a Program staff member or Program participant from criminal prosecution for a violation of any law prohibiting or regulating the […]
